Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00081510
Status:
COMPLETED
Last Update Posted:
2015-04-15
First Post:
2004-04-14
Brief Title:
Anastrozole Plus Lonafarnib SCH 66336 or Plus Placebo for the Treatment of Advanced Breast Cancer P03480
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-12
Start Date Type:
None
Primary Completion Date:
2009-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-05
Completion Date Type:
ACTUAL
First Submit Date:
2004-04-14
First Submit QC Date:
April 15 2004
Study First Post Date:
2004-04-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2009-04-17
Disp First Submit QC Date:
October 1 2009
Disp First Post Date:
2009-10-05
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-03-26
Last Update Post Date:
2015-04-15
Last Update Post Date Type:
ESTIMATED